NCT03184402View on ClinicalTrials.gov

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Functional Dyspepsia
Interventions
DRUG

DWJ1252

tablet

DRUG

Gasmotin

tablet

DRUG

Placebo of Gasmotin

tablet

DRUG

Placebo of DWJ1252

tablet

Trial Locations (1)

Unknown

Smg-Snu Boramae Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY